Fennec Pharmaceuticals Inc. SEC filings FENC
Fennec Pharmaceuticals Inc. has 853 filings in SEC EDGAR's recent list, going back to Dec 10, 2002. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 15, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2023 | — |
| EFFECT | Filing | Dec 12, 2022 | — |
| CORRESP | Letter to the SEC | Dec 8, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| EFFECT | Filing | Nov 10, 2020 | — |
| CORRESP | Letter to the SEC | Nov 6, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2020 | — |
| EFFECT | Filing | Apr 19, 2018 | — |
| EFFECT | Filing | Nov 3, 2017 | — |
| CORRESP | Letter to the SEC | Oct 31, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2017 | — |
| EFFECT | Filing | Sep 18, 2017 | — |
| CORRESP | Letter to the SEC | Sep 14, 2017 | — |
| 8-A12B | Filing | Sep 11, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2017 | — |
| CERTNAS | Auto-generated paper document | Aug 14, 2017 | — |
| D | Filing | Jun 8, 2017 | — |
| RW | Registration withdrawal request | Apr 11, 2016 | — |
| D | Filing | Dec 15, 2014 | — |
| SC TO-I/A | Filing | Aug 14, 2014 | — |
| CORRESP | Letter to the SEC | Jul 10, 2014 | — |
| SC TO-I/A | Filing | Jul 10, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2014 | — |
| SC TO-I | Filing | Jun 30, 2014 | — |
| EFFECT | Filing | May 14, 2014 | — |
| EFFECT | Filing | Apr 18, 2014 | — |
| AW | Filing | Apr 9, 2014 | — |
| D | Filing | Nov 27, 2013 | — |
| NT 10-Q | Filing | Nov 15, 2013 | Sep 30, 2013 |
| EFFECT | Filing | Apr 3, 2013 | — |
| EFFECT | Filing | Nov 10, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2011 | — |
| EFFECT | Filing | Feb 11, 2011 | — |
| CORRESP | Letter to the SEC | Feb 2, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2011 | — |
| CORRESP | Letter to the SEC | Jan 12, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2010 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2010 | — |
| CORRESP | Letter to the SEC | Nov 30, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2010 | — |
| NT 10-Q | Filing | Aug 16, 2010 | Jun 30, 2010 |
| EFFECT | Filing | Mar 30, 2010 | — |
| AW | Amendment to withdrawal | Mar 30, 2010 | — |
| 15-12B/A | Cert. and notice of termination | Oct 28, 2009 | — |
| 15-12B | Deregistration | Jul 17, 2009 | — |
| 25 | Adherex form 25 | Jan 20, 2009 | — |
| CT ORDER | Filing | Sep 12, 2008 | — |
| REGDEX/A | Auto-generated paper document | Mar 13, 2007 | — |
| REGDEX | Auto-generated paper document | Mar 7, 2007 | — |
| EFFECT | Filing | Jun 21, 2006 | — |
| CORRESP | Letter to the SEC | Jun 20, 2006 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2006 | — |
| REGDEX | Auto-generated paper document | May 23, 2006 | — |
| REGDEX | Auto-generated paper document | Jul 29, 2005 | — |
| REGDEX | Auto-generated paper document | Dec 27, 2004 | — |
| CERTAMX | Auto-generated paper document | Nov 9, 2004 | — |
| 20FR12B/A | Amendment no 2 to form 20-f | Nov 5, 2004 | — |
| 20FR12B/A | Amendment no 1 to form 20-f | Oct 8, 2004 | — |
| 20FR12B | Form 20-f registration statement | Sep 17, 2004 | — |
| REGDEX | Auto-generated paper document | Jun 9, 2004 | — |
| REGDEX | Auto-generated paper document | Jul 14, 2003 | — |
| REGDEX | Auto-generated paper document | Dec 10, 2002 | — |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- FENC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Research Triangle Park, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1211583
- Former names
- ADHEREX TECHNOLOGIES INC (until Aug 14, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.